S Gastrointestinal And Liver Disease 12th Edition Hot [portable] -

The 12th edition of Sleisenger and Fordtran is designed for quick, actionable clinical insights.

If you are looking to purchase, check your hospital library access or explore digital licensing options to leverage the real-time continuous monthly clinical updates.

The 12th edition dives deep into the "explosion" of new treatments for Inflammatory Bowel Disease (IBD)

The 12th edition of Sleisenger and Fordtran's Gastrointestinal and Liver Disease is available in a comprehensive two-volume set. With a publication date in late December 2025, demand is already high, and many retailers are offering pre-order options. The book is available in multiple formats:

The therapeutic landscape for liver disease has changed dramatically in recent years. The 12th edition covers , including the latest direct‑acting antivirals and strategies for hepatitis B functional cure. In addition, there is expanded coverage of new treatments for autoimmune liver diseases , such as primary biliary cholangitis (PBC) and autoimmune hepatitis, offering readers the most current management strategies. s gastrointestinal and liver disease 12th edition hot

, which is widely considered the definitive masterwork for gastroenterology and hepatology. Published by , this latest edition was released in December 2025 New and Key Features

Because of the high demand, major retailers (Amazon, Barnes & Noble) are experiencing rolling stockouts. As of this writing:

: Updates on new therapies for viral hepatitis, autoimmune liver diseases, and the expanding array of treatments for Inflammatory Bowel Disorders (IBD) Essential Features for Clinicians Visual & Practical Aids : The text includes over 1,100 full-color illustrations and more than 20 procedural videos accessible via the eBook. Decision Support

: Comprehensive parts dedicated to the Esophagus (Part VI), Stomach/Duodenum (Part VII), Pancreas (Part VIII), Biliary Tract (Part IX), and Liver (Part X). Features & Enhanced Learning Tools The 12th edition of Sleisenger and Fordtran is

If you’re deciding whether to upgrade your clinical library, here are the "hottest" updates in this latest release. 1. The Rise of AI in Endoscopy One of the most buzzworthy additions is the focus on Artificial Intelligence (AI)

This is for informational purposes only. For medical advice or diagnosis, consult a professional. AI responses may include mistakes. Learn more

(Metabolic dysfunction-associated steatotic liver disease, formerly NAFLD) and eosinophilic disorders Advanced Treatments

For over half a century, has remained the unrivaled "bible" of gastroenterology and hepatology. The release of the 12th edition in 2026 continues this legacy, offering an indispensable, two-volume masterwork that bridges the gap between basic science, clinical pathophysiology, and cutting-edge management. With a publication date in late December 2025,

"The motility section is entirely new. If you are still using the 11th edition for gastroparesis, you are practicing five-year-old medicine." —

Ask yourself these three questions:

Because demand is exceptionally high (supply chain issues led to a short initial print run), the 12th edition has been selling out at major medical conferences.

Sleisenger and Fordtran's Gastrointestinal and Liver Disease 12th edition is a comprehensive and authoritative textbook that continues to set the standard in gastroenterology. The book's updated chapters, new sections, and enhanced illustrations provide a thorough review of the latest advances in gastrointestinal and liver disease. As a result, it is an essential resource for healthcare professionals, researchers, and students seeking to stay up-to-date with the latest developments in the field. Whether you are a gastroenterologist, internal medicine physician, or trainee, this book is a valuable addition to your library, providing practical guidance on the diagnosis, treatment, and management of gastrointestinal and liver disease.